For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov:
The purpose of this study is to see if selinexor will improve the blood counts and bone marrow function in people with your type of MDS.
Fri, 08/01/2014 to Tue, 08/01/2017
Bone Marrow Disease(s):
myelodysplastic syndromes (MDS)
Drug: selinexor (KPT-330)